Journal of Interventional Medicine最新文献_第9页

Interventional treatments for hepatic hemangioma: A state-of-the-art review 肝血管瘤的介入治疗:最新进展综述

Journal of Interventional Medicine Pub Date : 2022-02-01 DOI: 10.1016/j.jimed.2021.12.009

Kefeng Jia, Zhongsong Gao, Ming Li, Changlu Yu

引用次数: 2

Angiography findings and endovascular management of acute nonvariceal gastrointestinal bleeding: A pictorial essay 急性非静脉性胃肠道出血的血管造影表现和血管内治疗：一篇图片文章

Journal of Interventional Medicine Pub Date : 2022-02-01 Epub Date: 2022-02-26 DOI: 10.1016/j.jimed.2021.12.001

Haiyang Yu, Junhao Mei, Lihao Qin, Zhongzhi Jia

引用次数: 0

Coexistence of situs inversus totalis and hepatocellular carcinoma: A series of nine cases and a literature review 完全性倒位与肝细胞癌共存:9例并文献复习

Journal of Interventional Medicine Pub Date : 2022-02-01 DOI: 10.1016/j.jimed.2021.12.007

Xiaowei Li, Z. Fu, Jiaming Zhong, Kunkun Cao, Xiaoxia Chen, N. Ding, Li Liu, J. Zhai, Zengqiang Qu

引用次数: 2

Molecular targeted therapy causes hepatic encephalopathy in patients after Transjugular intrahepatic portosystemic shunt (TIPS): A case report and literature review 分子靶向治疗引起经颈静脉肝内门体分流术（TIPS）后肝性脑病的病例报告和文献综述。

Journal of Interventional Medicine Pub Date : 2022-02-01 Epub Date: 2022-02-26 DOI: 10.1016/j.jimed.2021.12.006

Chen Zhou , Yang Chen , Jiacheng Liu , Qin Shi , Bin Xiong

引用次数: 1

Application of contrast-enhanced ultrasound in minimally invasive ablation of benign thyroid nodules 超声造影在甲状腺良性结节微创消融中的应用

Journal of Interventional Medicine Pub Date : 2022-02-01 DOI: 10.1016/j.jimed.2021.12.008

Jia-ying Cao, P. Fan, Feihang Wang, Shuainan Shi, Ling-xiao Liu, Zhiping Yan, Yi Dong, Wenping Wang

引用次数: 2

Application of contrast-enhanced ultrasound in minimally invasive ablation of benign thyroid nodules 超声造影在甲状腺良性结节微创消融中的应用

Journal of Interventional Medicine Pub Date : 2022-02-01 Epub Date: 2022-02-26 DOI: 10.1016/j.jimed.2021.12.008

Jiaying Cao , Peili Fan , Feihang Wang , Shuainan Shi , Lingxiao Liu , Zhiping Yan , Yi Dong , Wenping Wang

{"title":"Application of contrast-enhanced ultrasound in minimally invasive ablation of benign thyroid nodules","authors":"Jiaying Cao , Peili Fan , Feihang Wang , Shuainan Shi , Lingxiao Liu , Zhiping Yan , Yi Dong , Wenping Wang","doi":"10.1016/j.jimed.2021.12.008","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.12.008","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to investigate the application value of contrast-enhanced ultrasound (CEUS) before and after minimally invasive ablation procedures for benign thyroid nodule(s) (BTN).</p></div><div><h3>Methods</h3><p>This prospective study included patients with BTNs scheduled to undergo ultrasound-guided minimally invasive ablation treatment. CEUS was performed before and after ablation (at 1 day, and 1, 6, and 12 months after ablation). Changes in microvascular perfusion and the volume of BTNs were noted and assessed.</p></div><div><h3>Results</h3><p>Sixty-two patients (62 BTNs), who underwent ablation procedures between June 2016 and August 2020, were included. All lesions were confirmed by biopsy, and histopathological results were obtained before ablation treatment. On preoperative CEUS, the lesions exhibited hyperenhancement (53.23%) or iso-enhancement (46.77%) during the arterial phase, and all lesions exhibited iso-enhancement in the venous and late phases. One day after ablation, none of the BTNs exhibited obvious enhancement on CEUS. One (1.61%) lesion was re-treated due to a nodule-like enhancement area detected by CEUS at the 6-month follow-up. The mean nodular volume reduction rate (VRR) at 1, 6, and 12 months follow-up demonstrated no significant difference between the two ablation groups (microwave ablation versus radiofrequency ablation). Twelve months after ablation, the mean (±SD) VRR of all BTNs was 60.3 ± 10.3%.</p></div><div><h3>Conclusion</h3><p>CEUS helped guide treatment decisions for BTNs before ablation treatment. Moreover, it could also be used to accurately and noninvasively evaluate treatment efficacy.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"5 1","pages":"Pages 32-36"},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096360221000764/pdfft?md5=9d06fb4d54135f0e1b6daccbb1cab753&pid=1-s2.0-S2096360221000764-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72098920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study 成人恶性肿瘤导管口系统植入并发症的10年单中心回顾性研究

Journal of Interventional Medicine Pub Date : 2022-02-01 Epub Date: 2021-12-09 DOI: 10.1016/j.jimed.2021.12.002

Yong Li , Jianxi Guo , Yanfang Zhang, Jian Kong

{"title":"Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study","authors":"Yong Li , Jianxi Guo , Yanfang Zhang, Jian Kong","doi":"10.1016/j.jimed.2021.12.002","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.12.002","url":null,"abstract":"<div><h3>Background</h3><p>Port-A-Cath systems (PCS) are safe and convenient devices for long-term infusion in patients with malignant tumors. This study retrospectively analyzed the complications from PCS and their management.</p></div><div><h3>Methods</h3><p>Data of 1695 adults (641 males and 1054 females) with malignant tumors who underwent PCS implantation in our center from January 1, 2009 to December 31, 2019 who had complete follow-up records were collected in this study. The early and late complications and corresponding treatments were studied.</p></div><div><h3>Results</h3><p>A total of 1716 PCSs were implanted; 21 patients underwent 2 implantations each. The success rate was 100% and no severe complications occurred during implantation. The overall occurrence rate of post-implantation complications was 18.5% (318/1716); 5.5% (94/1716) were early complications and 13.0% (224/1716) were late complications. A total of 451 PCSs were removed, of which 398 were removed due to the end of chemotherapy, while 53 were removed because of complications. A total of 4 deaths occurred from these complications.</p></div><div><h3>Conclusions</h3><p>The incidence of intra- and post-operative complications is low. In most cases, complications can be effectively controlled without the removal of the PCS and regular follow-up and maintenance are critical.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"5 1","pages":"Pages 15-22"},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096360221000703/pdfft?md5=dc57dd05620b96ccad26aa03ca8221ba&pid=1-s2.0-S2096360221000703-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72097649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Interventional treatments for hepatic hemangioma: A state-of-the-art review 肝血管瘤的介入治疗进展

Journal of Interventional Medicine Pub Date : 2022-02-01 Epub Date: 2022-02-26 DOI: 10.1016/j.jimed.2021.12.009

Kefeng Jia, Zhongsong Gao, Mingge Li, Changlu Yu

引用次数: 3

Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study 成人恶性肿瘤置入术并发症:一项10年单中心回顾性研究

Journal of Interventional Medicine Pub Date : 2021-12-09 DOI: 10.1016/j.jimed.2021.12.002

Yong Li, Jianxi Guo, Yanfang Zhang, Jian Kong

引用次数: 0

Comparison of tumor response following conventional versus drug-eluting bead transarterial chemoembolization in early- and very early-stage hepatocellular carcinoma 早期和极早期肝癌常规与药物洗脱经动脉化疗栓塞后肿瘤反应的比较

Journal of Interventional Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.jimed.2021.12.004

M. Razi, S. Safiullah, J. Gu, Xu He, M. Razi, J. Kong

引用次数: 4